Things didn’t go well for Donald Trump’s first choice to lead the Centers for Disease Control and Prevention. Dr. Brenda Fitzgerald was ousted in January following a handful of embarrassing controversies, including reports that she bought shares in a tobacco company — after she became CDC director.
Yesterday, Health and Human Services Secretary Alex Azar announced her successor: Dr. Robert Redfield, a prominent AIDS researcher, is the new head of the CDC. At first blush, Redfield at least has the kind of background one might expect for this position — he’s a longtime virologist and physician — and unlike so many other Trump appointees, Redfield wants the agency he’ll lead to exist.
But this choice is not without critics. NBC News reported that Redfield has been accused of overseeing “shoddy HIV research.” Former Air Force Lt. Col. Craig Hendrix, a doctor who is now director of the division of clinical pharmacology at Johns Hopkins, worked with Redfield at the Walter Reed Army Institute of Research and told NBC, “Either he was egregiously sloppy with data or it was fabricated. It was somewhere on that spectrum, both of which were serious and raised questions about his trustworthiness.”
BuzzFeed’s report went a little further.









